Literature DB >> 18948254

Tau mutations in neurodegenerative diseases.

Michael S Wolfe1.   

Abstract

Tau deposition is found in a variety of neurodegenerative brain diseases. The identification of tau mutations that cause familial dementia demonstrated that aberrant Tau alone could cause neurodegenerative disease and suggested that Tau likely plays a role in other cases in which Tau deposits are found, most notably Alzheimer disease. The mechanisms by which tau mutations cause neurodegeneration vary and are unclear to some degree, but evidence supports changes in alternative splicing, phosphorylation state, interaction with tubulin, and self-association into filaments as important contributing factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948254     DOI: 10.1074/jbc.R800013200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.

Authors:  Susanne Wegmann; Jonas Schöler; Christian A Bippes; Eckhard Mandelkow; Daniel J Muller
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 4.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

5.  Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.

Authors:  Elka R Georgieva; Shifeng Xiao; Peter P Borbat; Jack H Freed; David Eliezer
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

Review 6.  Modeling ALS and FTD with iPSC-derived neurons.

Authors:  Sebum Lee; Eric J Huang
Journal:  Brain Res       Date:  2015-10-14       Impact factor: 3.252

7.  Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.

Authors:  Venkat Subramaniam; Gin Chuang; Huijing Xia; Brendan Burn; Jessica Bradley; Jerome L Maderdrut; David H Coy; Kurt J Varner
Journal:  Peptides       Date:  2017-07-15       Impact factor: 3.750

Review 8.  Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase.

Authors:  Elisabetta Lauretti; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA.

Authors:  Yang Liu; Eleanor Peacey; John Dickson; Christine P Donahue; Suxin Zheng; Gabriele Varani; Michael S Wolfe
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

10.  Global regulation of alternative splicing during myogenic differentiation.

Authors:  Christopher S Bland; Eric T Wang; Anthony Vu; Marjorie P David; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2010-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.